BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Publication » Donor Islet Endothelial Cells

Donor Islet Endothelial Cells

Endothelial cells lining surfaces of donor islets promote a faster initial blood vessel formation after transplantation. The results are published in Diabetes in October 2011.

Patients with type 1 diabetes lack insulin, as the majority of the pancreatic beta cells producing this vital hormone have been destroyed. Transplanting donor islets of Langerhans, built up primarily of beta cells, is one way to help these patients.

Directly upon transplantation, many cells die as they yet have not established contact to blood vessels for necessary supply of oxygen and nutrients. Endothelial cells lining the surfaces of the transplanted islets have previously been shown to enhance formation of blood vessels.

Using the InSight Technology, Professor Per-Olof Berggren’s research group has done a thorough analysis of donor islet endothelial cells (DIEC). Due to the capacity to detect events at the level of a single cell, it has been shown that the presence of DIEC leads to a faster initial blood vessel formation between the host and the donor tissue. As the experiments could be run during several weeks in the same animals, the scientists were also able to show that in general DIEC do not contribute to a larger number of blood vessels in the donor islets.

Read more:

Donor Islet Endothelial Cells in Pancreatic Islet Revascularization. Nykvist D et.al. Diabetes. 2011 Oct;60(10):2571-7

February 21, 2012 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved